Romano Vrabec

Zagreb, 10000, Croatia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Diagnostic Accuracy and Real-Life Advantages of the MONA.health Artificial Intelligence Software in Screening for Diabetic Retinopathy and Maculopathy.

Diagnostic Accuracy and Real-Life Advantages of the MONA.health Artificial Intelligence Software in Screening for Diabetic Retinopathy and Maculopathy.

Journal: Diagnostics (Basel, Switzerland)
Published: January 19, 2026

Association Between Macular Ganglion Cell-Inner Plexiform Layer and Non-Proliferative Retinopathy Without Macular Edema in Type 2 Diabetes via Diabetes Duration and HbA1c Link.

Association Between Macular Ganglion Cell-Inner Plexiform Layer and Non-Proliferative Retinopathy Without Macular Edema in Type 2 Diabetes via Diabetes Duration and HbA1c Link.

Journal: Biomedicines
Published: December 29, 2024

Patients with Type 2 Diabetes, Higher Blood Pressure, and Infrequent Fundus Examinations Have a Higher Risk of Sight-Threatening Retinopathy.

Patients with Type 2 Diabetes, Higher Blood Pressure, and Infrequent Fundus Examinations Have a Higher Risk of Sight-Threatening Retinopathy.

Journal: Journal of clinical medicine
Published: February 22, 2024

Diagnostic Accuracy of Hand-Held Fundus Camera and Artificial Intelligence in Diabetic Retinopathy Screening.

Diagnostic Accuracy of Hand-Held Fundus Camera and Artificial Intelligence in Diabetic Retinopathy Screening.

Journal: Biomedicines
Published: November 25, 2023

Systolic and Diastolic Blood Pressure Are Independent Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes.

Systolic and Diastolic Blood Pressure Are Independent Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes.

Journal: Biomedicines
Published: July 12, 2023

BLOOD PRESSURE IS ASSOCIATED 
WITH DIABETIC RETINOPATHY 
IN TYPE 1 BUT NOT IN TYPE 2 DIABETES.

BLOOD PRESSURE IS ASSOCIATED 
WITH DIABETIC RETINOPATHY 
IN TYPE 1 BUT NOT IN TYPE 2 DIABETES.

Journal: Acta clinica Croatica
Published: October 28, 2022

HDL cholesterol is a protective predictor in the development and progression of retinopathy in type 1 diabetes: A 15-year follow-up study.

HDL cholesterol is a protective predictor in the development and progression of retinopathy in type 1 diabetes: A 15-year follow-up study.

Journal: Diabetes research and clinical practice
Published: August 14, 2021

Hypertension and Hypercholesterolemia are Associated with Cataract Development in Patients with Type 2 Diabetes.

Hypertension and Hypercholesterolemia are Associated with Cataract Development in Patients with Type 2 Diabetes.

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: June 17, 2021

Plasma homocysteine is associated with nonproliferative retinopathy in patients with type 2 diabetes without renal disease.

Plasma homocysteine is associated with nonproliferative retinopathy in patients with type 2 diabetes without renal disease.

Journal: Diabetes & metabolic syndrome
Published: June 05, 2021

Systemic inflammation and dyslipidemia are associated with retinopathy in type 2 but not in type 1 diabetes.

Systemic inflammation and dyslipidemia are associated with retinopathy in type 2 but not in type 1 diabetes.

Journal: Scandinavian journal of clinical and laboratory investigation
Published: July 10, 2020

Diabetic Macular Edema: Traditional and Novel Treatment

Diabetic Macular Edema: Traditional and Novel Treatment

Journal: Acta clinica Croatica
Published: November 10, 2017
Showing 1-11 of 11

Last Updated: 09/26/2026